• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM Back to Search Results
Model Number AB2000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Urinary Retention (2119); Patient Problem/Medical Problem (2688)
Event Date 06/03/2020
Event Type  Injury  
Manufacturer Narrative
Product return is not available as the system in currently in use at the user facility.Investigation by manfacturer is currently in-process.
 
Event Description
A male patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation became aware that two (2) days post-aquablation procedure, and removal of the foley balloon catheter, the patient was taken back to the operating room (or) due to urinary retention (per manufacturer's instructions for use, urinary retention is perioperative risk of the aquablation procedure).A new foley balloon catheter was inserted for two (2) additional days; however, the patient continued to show urinary retention symptoms.The patient was taken back to the or for transurethral resection of the prostate (turp) surgery.Information received from the treating physician indicated that the event was not due to a malfunction of the aquabeam robotic system, as the patient continued to have urinary retention post-turp procedure.
 
Manufacturer Narrative
The aquabeam robotic system's log file was reviewed, which confirmed no malfunctions during the aquablation procedure.The review of the log file indicated that the system functioned as designed.A review of the device history record (dhr) serial number (b)(6) was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system.The review indicated that the system met all required specifications upon release for distribution.A review for similar complaints was performed on serial number (b)(6), which confirmed that there were no other similar events.A review across all lots found a similar event.The aquabeam robotic system's instructions for use (ifu), ifu0104-00, was reviewed and urinary retention is listed as a potential perioperative risk of the aquablation procedure.A root cause for the reported event could not be determined.Urinary retention is a potential risk of the aquablation procedure.Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Event Description
A male patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation became aware that two (2) days post-aquablation procedure, and removal of the foley balloon catheter, the patient was taken back to the operating room (or) due to clot retention (per manufacturer's instructions for use, bleeding is perioperative risk of the aquablation procedure).A new foley balloon catheter was inserted for two (2) additional days; however, the patient continued to show retention symptoms.The patient was taken back to the or for transurethral resection of the prostate (turp) surgery.Information received from the treating physician indicated that the event was not due to a malfunction of the aquabeam robotic system, as the patient continued to have urinary retention post-turp procedure.
 
Manufacturer Narrative
H.11 corrected data: 1) b5.Describe event or problem - please refer to updated description of event.2) h.6 event problem evalucation codes.The correct health effect - clinical code is "1888 - hemorrhage/bleeding".3) h.10 additional manufacturer narrative: the aquabeam robotic system's instructions for use (ifu), ifu0104-00, was reviewed and bleeding is listed as a potential perioperative risk of the aquablation procedure.A root cause for the reported event could not be determined.Bleeding is a potential risk of the aquablation procedure.Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Manufacturer Narrative
H.11 corrected data: h.1 type of reportable event: the follow-up #1 was incorrectly reported as an malfunction.The correct selection should have been serious injury.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUABEAM ROBOTIC SYSTEM
Type of Device
FLUID JET REMOVAL SYSTEM
Manufacturer (Section D)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city CA 94065 1494
MDR Report Key10255818
MDR Text Key199313679
Report Number3012977056-2020-00021
Device Sequence Number1
Product Code PZP
UDI-Device IdentifierB614AB20001
UDI-PublicB614AB20001
Combination Product (y/n)N
PMA/PMN Number
DEN170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup,Followup
Report Date 05/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAB2000
Device Catalogue NumberAB2000
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/09/2020
Initial Date FDA Received07/09/2020
Supplement Dates Manufacturer Received10/02/2020
04/15/2021
05/21/2021
Supplement Dates FDA Received10/12/2020
04/23/2021
05/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-